Author:
Pérez Catalán Ignacio,Roig Martí Celia,Andrés Soler Jorge,Fabra Juana Sergio,Gomila Sard Bárbara,Usó Blasco Jorge,Caminero José Antonio
Reference15 articles.
1. Classification of anti-TB drugs: a new potential proposal based on the most recent evidence;Caminero;Eur Respir J,2015
2. Executive summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis;Nahid;Clin Infect Dis,2016
3. Adverse anti-tuberculosis drug events and their management;Caminero,2018
4. Leukopenia due to an tuberculous chemotherapy including rifampicin and isoniazid;Nagayama;Kekkaku,2004
5. A cross-sectional and follow-up study of leukopenia in tuberculosis patients: prevalence, risk factors and impact of anti-tuberculosis treatment;Lin;J Thorac Dis,2015